Jane Street’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.36B | Sell |
1,473,800
-1,662,700
| -53% | -$1.69B | 0.17% | 73 |
|
|
2025
Q4 | $3.37B | Buy |
3,136,500
+1,028,100
| +49% | +$983M | 0.51% | 32 |
|
|
2025
Q3 | $1.61B | Sell |
2,108,400
-17,200
| -0.8% | -$12.8M | 0.24% | 57 |
|
|
2025
Q2 | $1.66B | Buy |
2,125,600
+998,400
| +89% | +$776M | 0.33% | 41 |
|
|
2025
Q1 | $931M | Sell |
1,127,200
-591,700
| -34% | -$492M | 0.23% | 49 |
|
|
2024
Q4 | $1.33B | Buy |
1,718,900
+703,700
| +69% | +$583M | 0.29% | 38 |
|
|
2024
Q3 | $899M | Buy |
1,015,200
+259,600
| +34% | +$233M | 0.2% | 52 |
|
|
2024
Q2 | $684M | Sell |
755,600
-431,000
| -36% | -$345M | 0.16% | 67 |
|
|
2024
Q1 | $923M | Buy |
1,186,600
+368,000
| +45% | +$262M | 0.19% | 54 |
|
|
2023
Q4 | $477M | Sell |
818,600
-6,300
| -0.8% | -$3.68M | 0.12% | 88 |
|
|
2023
Q3 | $443M | Buy |
824,900
+175,800
| +27% | +$90.6M | 0.14% | 64 |
|
|
2023
Q2 | $304M | Buy |
649,100
+245,900
| +61% | +$103M | 0.1% | 97 |
|
|
2023
Q1 | $138M | Buy |
403,200
+143,900
| +55% | +$48.5M | 0.06% | 222 |
|
|
2022
Q4 | $94.9M | Sell |
259,300
-287,800
| -53% | -$102M | 0.04% | 313 |
|
|
2022
Q3 | $177M | Sell |
547,100
-151,100
| -22% | -$47.9M | 0.08% | 150 |
|
|
2022
Q2 | $226M | Buy |
698,200
+334,800
| +92% | +$100M | 0.1% | 129 |
|
|
2022
Q1 | $104M | Buy |
363,400
+75,500
| +26% | +$19.4M | 0.03% | 375 |
|
|
2021
Q4 | $79.5M | Sell |
287,900
-22,600
| -7% | -$5.73M | 0.03% | 455 |
|
|
2021
Q3 | $71.7M | Buy |
310,500
+30,100
| +11% | +$7.43M | 0.03% | 452 |
|
|
2021
Q2 | $64.4M | Buy |
280,400
+98,700
| +54% | +$19.8M | 0.03% | 446 |
|
|
2021
Q1 | $33.9M | Sell |
181,700
-24,500
| -12% | -$4.79M | 0.02% | 636 |
|
|
2020
Q4 | $34.8M | Buy |
206,200
+50,900
| +33% | +$7.6M | 0.02% | 573 |
|
|
2020
Q3 | $23M | Sell |
155,300
-96,400
| -38% | -$14.9M | 0.01% | 700 |
|
|
2020
Q2 | $41.3M | Buy |
251,700
+110,200
| +78% | +$16.9M | 0.03% | 417 |
|
|
2020
Q1 | $19.6M | Buy |
141,500
+49,100
| +53% | +$6.75M | 0.02% | 471 |
|
|
2019
Q4 | $12.1M | Buy |
92,400
+30,100
| +48% | +$3.49M | 0.02% | 560 |
|
|
2019
Q3 | $6.97M | Sell |
62,300
-1,400
| -2% | -$156K | 0.01% | 771 |
|
|
2019
Q2 | $7.06M | Buy |
+63,700
| New | +$7.5M | 0.01% | 830 |
|
|
2019
Q1 | – | Sell |
-100,600
| Closed | -$11.6M | – | 5368 |
|
|
2018
Q4 | $11.6M | Buy |
100,600
+6,200
| +7% | +$693K | 0.02% | 500 |
|
|
2018
Q3 | $10.1M | Buy |
94,400
+19,200
| +26% | +$1.92M | 0.02% | 597 |
|
|
2018
Q2 | $6.42M | Buy |
75,200
+30,800
| +69% | +$2.53M | 0.02% | 860 |
|
|
2018
Q1 | $3.44M | Buy |
44,400
+38,600
| +666% | +$3.11M | 0.01% | 1279 |
|
|
2017
Q4 | $490K | Sell |
5,800
-19,200
| -77% | -$1.63M | ﹤0.01% | 3205 |
|
|
2017
Q3 | $2.14M | Sell |
25,000
-6,800
| -21% | -$558K | 0.01% | 1537 |
|
|
2017
Q2 | $2.62M | Buy |
31,800
+19,200
| +152% | +$1.57M | 0.01% | 1245 |
|
|
2017
Q1 | $1.06M | Sell |
12,600
-107,700
| -90% | -$8.63M | ﹤0.01% | 2009 |
|
|
2016
Q4 | $8.85M | Buy |
120,300
+94,500
| +366% | +$7.04M | 0.04% | 412 |
|
|
2016
Q3 | $2.07M | Sell |
25,800
-70,800
| -73% | -$5.67M | 0.01% | 1178 |
|
|
2016
Q2 | $7.61M | Buy |
96,600
+79,300
| +458% | +$5.97M | 0.04% | 434 |
|
|
2016
Q1 | $1.25M | Sell |
17,300
-31,000
| -64% | -$2.35M | 0.01% | 1649 |
|
|
2015
Q4 | $4.07M | Buy |
48,300
+15,000
| +45% | +$1.24M | 0.03% | 609 |
|
|
2015
Q3 | $2.79M | Buy |
+33,300
| New | +$2.81M | 0.02% | 748 |
|
|
2015
Q2 | – | Sell |
-6,300
| Closed | -$458K | – | 3863 |
|
|
2015
Q1 | $458K | Buy |
+6,300
| New | +$449K | ﹤0.01% | 2131 |
|
Other funds holding LLY
VCM
VPM
Jane Street's LLY Position: Q1 2026 in Review
Jane Street reduced its Eli Lilly (LLY) stake by 55% in Q1 2026, selling an estimated $141M and leaving 115,863 shares worth $107M. The position accounts for 0.01% of the portfolio, ranked #613.
Jane Street first reported a position in LLY in Q2 2013 and has held it in 49 quarters since. The position peaked at $488M in Q3 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Jane Street held 115,863 shares of Eli Lilly worth $107M as of Q1 2026.
- Jane Street sold 139,261 Eli Lilly shares in Q1 2026, an estimated $141M.
- Eli Lilly made up 0.01% of Jane Street's portfolio in Q1 2026, its #613 holding.
- Jane Street first reported a position in Eli Lilly in Q2 2013 and has held it in 49 quarters since.
- Jane Street's Eli Lilly position peaked at $488M in Q3 2024.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.